INSULET CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171.9 USD | +0.99% |
|
+2.79% | -20.76% |
| 03-20 | US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady | MT |
| 03-20 | Insulet Names Ana Maria Chadwick Finance Chief | MT |
Chart calendar Insulet Corporation
8f7b1ad577d1.y2Bes20jIoXHjQzchp_gB-rb_pGpo_GjOf_V0Z7GBz8.oSgVhidWc_yovz-X1ayaMNzstqPu1JCOerSygM_yaVmZFjjhC3lUqJ3jSQ~4c3510d51a2e9fbd20798bc15072fcce
Upcoming events on Insulet Corporation
Past events on Insulet Corporation
| 05/03/2024 16:35 | Raymond James Institutional Investors Conference |
| 22/02/2024 21:30 | Q4 2023 Earnings Call |
| 22/02/2024 21:07 | Q4 2023 Earnings Release |
| 09/01/2024 17:45 | JPMorgan Healthcare Conference |
| 05/12/2023 15:00 | Nasdaq Investor Conference |
| 04/12/2023 11:30 | European Association for the Study of Diabetes Meeting - MDI or Pod |
| 02/11/2023 20:30 | Q3 2023 Earnings Call |
| 02/11/2023 20:01 | Q3 2023 Earnings Release |
| 05/10/2023 14:30 | European Association for the Study of Diabetes Meeting - OP 38 |
| 05/10/2023 13:00 | European Association for the Study of Diabetes Meeting - SO 60 |
| 05/10/2023 11:45 | European Association for the Study of Diabetes Meeting - SO 59 |
| 05/10/2023 11:30 | European Association for the Study of Diabetes Meeting - Omnipod 5 Open Q&A |
| 03/10/2023 11:30 | European Association for the Study of Diabetes Meeting - Omnipod |
| 13/09/2023 18:35 | Morgan Stanley Global Healthcare Conference |
| 12/09/2023 19:35 | Baird Global Healthcare Conference |
| 07/09/2023 14:30 | Wells Fargo Healthcare Conference |
| 08/08/2023 21:30 | Q2 2023 Earnings Call |
| 08/08/2023 21:01 | Q2 2023 Earnings Release |
| 23/05/2023 13:00 | Annual General Meeting |
| 04/05/2023 21:30 | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 738 727 1.54% | 904 892 1.4% | 1 099 1 091 0.73% | 1 305 1 267 3.03% | 1 697 1 648 2.99% | 1 961 |
|
EBITDA Million USD | Released Forecast Spread | 77,9 71,5 8.98% | 122 111 9.05% | 183 170 7.71% | 225 182 23.53% | 329 283 16.46% | 398 |
|
EBIT Million USD | Released Forecast Spread | 50,0 49,3 1.42% | 66,1 67,6 -2.19% | 126 115 9.11% | 124 73,9 67.86% | 209 160 30.71% | 255 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 14,5 16,6 -12.77% | 9,70 26,7 -63.61% | 20,5 17,2 19.01% | 9,80 33,1 -70.36% | 215 150 43.5% | 252 |
|
Net income Million USD | Released Forecast Spread | 11,6 13,4 -13.33% | 6,80 21,7 -68.62% | 16,8 11,4 47.66% | 4,60 18,8 -75.51% | 206 140 47.15% | 215 |
|
EPS USD | Released Forecast Spread | 0,19 0,22 -12.13% | 0,10 0,32 -69.11% | 0,24 0,17 39.15% | 0,07 0,21 -66.41% | 2,94 1,99 48% | 2,94 |
| Announcement Date | 25/02/20 | 23/02/21 | 23/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 308 301 2.37% | 295 288 2.57% | 299 291 2.93% | 341 311 9.42% | 370 332 11.44% | 358 330 8.45% | 397 385 2.96% | 433 414 4.47% | 510 461 10.57% | 425 | 456 | 507 | 571 | 523 |
|
EBITDA Million USD | Released Forecast Spread | 64,6 53,4 20.91% | 63,0 56,8 10.99% | 27,6 51,7 -46.59% | 62,8 41,7 50.75% | 71,4 48,4 47.52% | 48,8 67,7 -27.93% | 61,3 55,0 11.46% | 82,8 64,1 29.12% | 137 86,3 58.83% | 79,8 | 80,6 | 103 | 135 | 137 |
|
EBIT Million USD | Released Forecast Spread | 49,7 40,6 22.54% | 37,9 32,3 17.26% | -26,7 28,5 -193.69% | 2,90 21,7 -86.65% | 42,5 25,1 69.66% | 19,7 15,2 29.25% | 30,3 26,6 13.84% | 52,9 38,6 36.91% | 106 56,8 85.73% | 32,5 | 47,1 | 71,6 | 104 | 56,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 33,4 26,5 26.02% | 29,3 20,0 46.8% | -36,1 19,7 -283.16% | -5,70 11,3 -150.29% | 22,3 16,3 36.67% | 24,6 11,3 117.07% | 28,5 22,9 24.34% | 53,7 32,5 65.05% | 108 54,8 96.67% | 37,2 | 52,1 | 69,5 | 96,2 | 57,5 |
|
Net income Million USD | Released Forecast Spread | 29,2 21,9 33.39% | 27,8 16,5 68.21% | -35,0 17,1 -304.44% | -5,20 9,99 -152.04% | 17,0 14,3 19.21% | 23,8 9,70 145.33% | 27,3 17,6 55.2% | 51,9 27,3 90.41% | 103 45,6 126.58% | 30,3 | 42,5 | 59,4 | 82,0 | 48,4 |
|
EPS USD | Released Forecast Spread | 0,42 0,31 35.5% | 0,40 0,23 71.45% | -0,50 0,23 -318.09% | -0,08 0,15 -154.58% | 0,24 0,21 15.26% | 0,34 0,12 194.4% | 0,39 0,26 50.83% | 0,74 0,38 92.67% | 1,44 0,63 126.86% | 0,40 | 0,57 | 0,83 | 1,14 | 0,66 |
| Announcement Date | 23/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 08/08/23 | 02/11/23 | 22/02/24 | - | - | - | - | - |
| Today 21:01 | ATRICURE, INC.: Q1 2024 Earnings Release |
| Today 21:10 | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | DENTSPLY SIRONA INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | TELEFLEX INCORPORATED: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | ZIMMER BIOMET HOLDINGS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | BECTON, DICKINSON AND COMPANY: Q2 2024 Earnings Release |
| 02/05/2024 12:00 | AVANOS MEDICAL, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:15 | BAXTER INTERNATIONAL INC.: Q1 2024 Earnings Release |
| 05/05/2024 | TAIDOC TECHNOLOGY CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Insulet Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PODD Stock
- Calendar Insulet Corporation
